Molnupiravir for the treatment of COVID-19

Molnupiravir is four capsules “The second antiviral, molnupiravir, is a dose of 800 milligrams total,” said Dr Choi That means a patient is taking

Safety was assessed in all participants who took at least one dose of the medication The viral clearance rate was derived under a Bayesian

molnupiravir ราคา doses, and received a booster dose Molnupiravir use was also associated with reduced risk of PASC in those with primary SARS-CoV-2

molnupiravir dose Molnupiravir was safe and well tolerated; a dose of 800mg twice-daily for 5 days was recommended for Phase II evaluation Background AGILE is a phase IbIIa